Abstract
Patients with multiple measurable metastases can be used as their own perfectly matched controls to study the effect of different treatments on their metastases. Response to treatment may be assessed by sequential measurement of the regression and regrowth of the metastases and by assessment of the growth delay produced by each treatment. Three patients are described who have been studied in this way to investigate the addition of misonidazole to radiation. The results suggest that it is possible to obtain quantitative data that will discriminate between relatively small doses of radiation and provide interesting clinical information on tumour response. The problems of the method and its possible applications are discussed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ash D. V., Smith M. R., Bugden R. D. Distribution of misonidazole in human tumours and normal tissues. Br J Cancer. 1979 May;39(5):503–509. doi: 10.1038/bjc.1979.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brenner M. W., Holsti L. R., Perttala Y. The study by graphical analysis of the growth of human tumours and metastases of the lung. Br J Cancer. 1967 Mar;21(1):1–13. doi: 10.1038/bjc.1967.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Breur K. Growth rate and radiosensitivity of human tumours. I. Growth rate of human tumours. Eur J Cancer. 1966 Jun;2(2):157–171. doi: 10.1016/0014-2964(66)90008-9. [DOI] [PubMed] [Google Scholar]
- Breur K., van Peperzeel H. A. Possible clinical models for quantitative comparison of effects of different radiations on tumours. Eur J Cancer. 1971 May;7(2):199–203. doi: 10.1016/0014-2964(71)90017-x. [DOI] [PubMed] [Google Scholar]
- Thomlinson R. H., Dische S., Gray A. J., Errington L. M. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours. Clin Radiol. 1976 Apr;27(2):167–174. doi: 10.1016/s0009-9260(76)80139-0. [DOI] [PubMed] [Google Scholar]